Wednesday, September 14, 2016

Cancidas




In the US, Cancidas (caspofungin systemic) is a member of the drug class echinocandins and is used to treat Aspergillosis - Invasive, Candida Infections - Systemic, Esophageal Candidiasis and Febrile Neutropenia.

US matches:

  • Cancidas

UK matches:

  • CANCIDAS 50 mg (formerly Caspofungin MSD)
  • CANCIDAS 70 mg (formerly Caspofungin MSD)
  • CANCIDAS (formerly Caspofungin MSD) (SPC)

Ingredient matches for Cancidas



Caspofungin

Caspofungin is reported as an ingredient of Cancidas in the following countries:


  • Spain

  • Tunisia

Caspofungin diacetate (a derivative of Caspofungin) is reported as an ingredient of Cancidas in the following countries:


  • Algeria

  • Argentina

  • Aruba

  • Australia

  • Austria

  • Bahamas

  • Barbados

  • Belgium

  • Belize

  • Bosnia & Herzegowina

  • Brazil

  • Canada

  • Cayman Islands

  • Chile

  • China

  • Colombia

  • Croatia (Hrvatska)

  • Czech Republic

  • Denmark

  • Dominican Republic

  • Ecuador

  • Finland

  • France

  • Germany

  • Greece

  • Hong Kong

  • Hungary

  • Iceland

  • Ireland

  • Israel

  • Italy

  • Jamaica

  • Luxembourg

  • Malaysia

  • Mexico

  • Netherlands

  • Netherlands Antilles

  • New Zealand

  • Norway

  • Peru

  • Philippines

  • Romania

  • Russian Federation

  • Serbia

  • Singapore

  • Slovakia

  • Slovenia

  • South Africa

  • Sweden

  • Switzerland

  • Taiwan

  • Thailand

  • Trinidad & Tobago

  • Turkey

  • United Kingdom

  • United States

  • Venezuela

International Drug Name Search

Glossary

SPC Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.

No comments:

Post a Comment